We postulate that augmented hepatic IDE activity in response to glucose and insulin could serve as a mechanism that preserves hepatocytes from being exposed to high levels of portal insulin, resulting in the downregulation of the insulin receptor and appearance of insulin resistance. This evidence concerns the gene INS and Insulin resistance.